Inmune Bio, Inc. (INMB) stock
INMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.03+0.07 (+7.29%)
Close on Nov 18, 2026Market cap $28.59MP/E –Yield –
Inmune Bio market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Inmune Bio's market cap was $30.42M on Nov 11, 2026, against $46.26M a year earlier. Over the last 5 years it ranged from $30.04M to $225.27M, with a median of $130.83M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $30.42M | -26.7% |
| 2025 | Dec 31, 2025 | $41.47M | -59.9% |
| 2024 | Dec 31, 2024 | $103.55M | -48.8% |
| 2023 | Dec 29, 2023 | $202.07M | +77.6% |
| 2022 | Dec 30, 2022 | $113.78M | -37.5% |
| 2021 | Dec 31, 2021 | $182.00M | -21.4% |
| 2020 | Dec 31, 2020 | $231.57M | +271.0% |
| 2019 | Dec 31, 2019 | $62.42M | – |
See a number that looks wrong?